thromboxanes has been researched along with Kawasaki Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hidaka, T; Komatsu, Y; Nakano, M; Ueta, T; Yamamoto, M | 1 |
| Backon, J | 1 |
2 other study(ies) available for thromboxanes and Kawasaki Disease
| Article | Year |
|---|---|
Increased synthesis of thromboxane A2 by platelets from patients with Kawasaki disease.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Child, Preschool; Humans; Infant; Lymphatic Diseases; Mucocutaneous Lymph Node Syndrome; Thromboxane A2; Thromboxanes | 1983 |
Implication of thromboxane in the pathogenesis of Kawasaki disease and a suggestion for using novel thromboxane synthetase inhibitors in its treatment.
Topics: Carbon Dioxide; Child; Humans; Mucocutaneous Lymph Node Syndrome; Plants, Medicinal; Thromboxane-A Synthase; Thromboxanes | 1991 |